USD 1.29
(4.88%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 777.53 Thousand USD | -20.65% |
2023 | 979.9 Thousand USD | 97990600.0% |
2022 | 1.00 USD | 100.0% |
2021 | -3.2 Million USD | -270.61% |
2020 | 1.88 Million USD | -5.08% |
2019 | 1.98 Million USD | -2.33% |
2018 | 2.02 Million USD | 0.0% |
2017 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 942.05 Thousand USD | -2.39% |
2024 Q3 | 877.9 Thousand USD | -6.81% |
2024 FY | 777.53 Thousand USD | -20.65% |
2024 Q4 | 777.53 Thousand USD | -11.43% |
2024 Q1 | 965.09 Thousand USD | -1.51% |
2023 FY | 979.9 Thousand USD | 97990600.0% |
2023 Q1 | 300 Thousand USD | 29999900.0% |
2023 Q4 | 979.9 Thousand USD | 33.1% |
2023 Q3 | 736.22 Thousand USD | 9.73% |
2023 Q2 | 670.96 Thousand USD | 123.66% |
2022 Q4 | 1.00 USD | 0.0% |
2022 FY | 1.00 USD | 100.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 100.0% |
2022 Q2 | - USD | 0.0% |
2021 Q4 | -3.2 Million USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 FY | -3.2 Million USD | -270.61% |
2021 Q1 | - USD | -100.0% |
2021 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | 1.88 Million USD | -5.08% |
2020 Q4 | 1.88 Million USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | 1.98 Million USD | -2.33% |
2019 Q4 | - USD | 0.0% |
2018 Q4 | 2.02 Million USD | 0.0% |
2018 FY | 2.02 Million USD | 0.0% |
2017 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -135.598% |
Aspira Women's Health Inc. | 227 Thousand USD | -242.527% |
Biodesix, Inc. | 1.4 Million USD | 44.462% |
BioNexus Gene Lab Corp. | 1.13 Million USD | 31.661% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -4106.541% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -4106.541% |
Bionano Genomics, Inc. | 22.89 Million USD | 96.604% |
CareDx, Inc | 19.47 Million USD | 96.007% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 90.21% |
DarioHealth Corp. | 5.06 Million USD | 84.64% |
Exact Sciences Corporation | 127.47 Million USD | 99.39% |
Fulgent Genetics, Inc. | 5.82 Million USD | 86.656% |
Guardant Health, Inc. | 61.94 Million USD | 98.745% |
ICON Public Limited Company | 1.00 USD | -77753600.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 99.796% |
Illumina, Inc. | 587 Million USD | 99.868% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 96.213% |
MDxHealth SA | 2.77 Million USD | 72.021% |
23andMe Holding Co. | 12.46 Million USD | 93.762% |
Medpace Holdings, Inc. | 1.00 USD | -77753600.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 96.132% |
Mainz Biomed B.V. | 613.63 Thousand USD | -26.709% |
ENDRA Life Sciences Inc. | 2.62 Million USD | 70.355% |
NeoGenomics, Inc. | 24.15 Million USD | 96.781% |
Neogen Corporation | 189.26 Million USD | 99.589% |
Inotiv, Inc. | 56.1 Million USD | 98.614% |
Natera, Inc. | 40.75 Million USD | 98.092% |
OpGen, Inc. | 1.00 USD | -77753600.0% |
OPKO Health, Inc. | 65.69 Million USD | 98.816% |
Psychemedics Corporation | 1.00 USD | -77753600.0% |
Prenetics Global Limited | 3.12 Million USD | 75.133% |
Prenetics Global Limited | 3.12 Million USD | 75.133% |
Precipio, Inc. | 384 Thousand USD | -102.484% |
Personalis, Inc. | 5.66 Million USD | 86.265% |
RadNet, Inc. | 1.00 USD | -77753600.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 98.504% |
Neuronetics, Inc. | 8.09 Million USD | 90.392% |
Star Equity Holdings, Inc. | 3.42 Million USD | 77.265% |
Star Equity Holdings, Inc. | 3.42 Million USD | 77.265% |
Trinity Biotech plc | 19.93 Million USD | 96.099% |
T2 Biosystems, Inc. | 4.81 Million USD | 83.865% |
Twist Bioscience Corporation | 32.06 Million USD | 97.575% |
Exagen Inc. | 2.87 Million USD | 72.918% |